Vivos announces expanded applications of IsoPet® for veterinary cancer therapy
Vivos announced that the device classification obtained from the FDA Center for Veterinary Medicine is not limited to canine and feline sarcomas, and can be extended to a much broader population of veterinary cancers, essentially all solid tumors in animals. January 11, 2019